Latest Diabetes: Type II news
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
posted May 31st
by modernClinician Editorial Team
by modernClinician Editorial Team
GLP-1 Receptor Agonist Dispensing Up From 2020 to 2023 for Teens, Young Adults
posted May 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Intensive HTN Treatment Cuts Early T2D Diagnosis-Linked CVD Event Risk
posted April 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
ACP: Recommendations Developed for Newer Type 2 Diabetes Medications
posted April 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 Related Articles
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Type 2 Diabetes Linked to Worse Menopausal Symptoms 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk Monthly Specialist Briefings
Stay Connected
